• <td id="46i6g"><rt id="46i6g"></rt></td>
    <td id="46i6g"><kbd id="46i6g"></kbd></td>
  • <xmp id="46i6g"><option id="46i6g"></option><option id="46i6g"><option id="46i6g"></option></option>
  • <td id="46i6g"></td>
    發布時間:2019-04-27 15:58 原文鏈接: PreparationofSegmentedandPolarityMarkedMicrotubules

    Segmented and polarity-marked microtubules are very useful for many different types of in vitro assays. Segmented microtubules are microtubules with a bright seed and dim elongated segments on both ends. Polarity marked microtubules are microtubules with a bright seed and a dim elongated segment only on one end -- the plus end. Selective elongation of one end is achieved by inclusion of NEM-treated tubulin, a competitive inhibitor of minus end polymerization. More complex microtubule substrates such as GDP microtubule lattices capped with segments of GMPCPP tubulin can also be prepared by playing around with in vitro polymerization conditions. Also, segmented and polarity marked microtubules can be made from different color tubulins instead of different intensity of a single color tubulin as described here.

    Note that the precise ratios of labeled to unlabeled tubulin described here may need to be adjusted depending on the labeled tubulin prep. Described here is what has worked well for us using tetramethylrhodamine NHS ester-labeled tubulin (stoichiometry of labeling ~1.4).





    Back to protocols



    I. Solutions & Supplies


    BRB80 (1X): 80 mM PIPES, 1 mM MgCl2, 1 mM EGTA, pH 6.8 with KOH (generally made as a 5X stock and stored at 4?C)

    100 mM GTP

    100 mM GMPCPP

    Taxol: 10 mM stock; 200 μM, 20 μM and 2 μM dilution all in anhydrous DMSO; sold under tradename "Paclitaxel" by Sigma

    Bright GMPCPP Seed Mix (2 mg/ml; 1 part rhodamine tubulin to 2 parts unlabeled tubulin; prepared and stored at -80?C as described above)

    NEM GTP-Tubulin (prepared by treating recycled tubulin (~5-15 mg/ml) in BRB80 + 0.5 mM GTP with 1 mM NEM (N-ethylmaleimide; from a fresh 50 mM stock in water prepared just before use) for 10' at 0?C, quenching the NEM with 8 mM b-mercaptoethanol for 10' at 0?C, freezing aliquots in liquid nitrogen and storing at -80?C.

    NEM CPP-Tubulin (prepared by treating recycled tubulin (~5-15 mg/ml) in BRB80 + 0.5 mM GMPCPP with 1 mM NEM (freshly prepared as a 50 mM stock in water) for 10' at 0?C, quenching NEM with 8 mM b-mercaptoethanol for 10' at 0?C, freezing aliquots in liquid nitrogen and storing at -80?C.



    II. Segmented Taxol Microtubules


    1. Polymerize bright GMPCPP seed mix at 37?C for 15'-30'.

    2. On ice prepare the dim elongation mix consisting of 15 μM tubulin (1 partrhodamine tubulin to 10 parts unlabeled tubulin) in 1X BRB80, 1 mM DTT, 1 mM GTP. Incubate at 0?C for 5' and (optionally) clarify at 90K for 5' at 2?C in a TLA100 rotor.

    3. Incubate dim elongation mix at 37?C for 1'. Add 1/10-1/20 volume of GMPCPP seeds and mix gently. Incubate at 37?C for 20'. GMPCPP seeds are cold-labile and will depolymerize on ice. Therefore, only add the seeds after the elongation mix has warmed up.

    4. Add taxol stepwise to 20 μM.

    5. The segmented taxol-stabilized microtubules can be pelleted over a glycerol cushion and resuspended, or used directly after dilution. All dilutions of taxol-stabilized MTs should be done into buffers containing 10-20 μM taxol.



    III. Polarity Marked Taxol Microtubules


    1. Polymerize bright GMPCPP seed mix at 37?C for 15'-30'.

    2. On ice prepare the dim polar elongation mix consisting of 15 μM tubulin (1 partrhodamine tubulin to 10 parts unlabeled tubulin) and 12 μM NEM GTP-tubulin in 1X BRB80, 1 mM DTT, 1 mM GTP. Incubate at 0?C for 5' and (optionally) clarify at 90K for 5' at 2?C in a TLA100 rotor.

    3. Incubate dim polar elongation mix at 37?C for 1'. Add 1/10-1/20 volume of GMPCPP seeds and mix gently. Incubate at 37?C for 20'.

    4. Add taxol stepwise to 20 μM.

    5. The polarity-marked taxol-stabilized microtubules can be pelleted over a glycerol cushion and resuspended, or used directly after dilution. All dilutions of taxol-stabilized MTs should be done into buffers containing 10-20 μM taxol.



    IV. Segmented GMPCPP Microtubules


    1. Prepare dim GMPCPP Elongation Mix: 10 μM (1 mg/ml) 1:9 rhodamine labeled:unlabeled tubulin in 1X BRB80, 1 mM DTT, 0.5 mM GMPCPP. Incubate on ice for 5'-10', spin 90K 5' in TLA100 at 2?C, freeze in liquid nitrogen in 10 μl aliquots (or use fresh).

    2. Thaw GMPCPP bright seed mix by adding 9 vol of warm (37?C) BRB80 + 1 mM DTT (resulting in 2 μM tubulin final) and incubate at 37?C for 30'-45'.

    3. Thaw CPP elongation mix and store on ice. Dilute as follows on ice:

    17 μl BRB80 + 1 mM DTT
    3 μl CPP elongation mix

    (This results in elongation of ~1.5 μM CPP-tubulin)

    4. Incubate diluted CPP elongation mix at 37?C for 20 sec before adding 2 μl of polymerized bright CPP seeds.

    5. Incubate at 37?C for 1-2 hours. Pellet and resuspend or use directly.



    V. Polarity Marked GMPCPP Microtubules


    1. Prepare dim GMPCPP polar elongation mix: 10 μM (1 mg/ml) 1:9 rhodamine labeled:unlabeled tubulin and 8 μM NEM CPP-Tubulin in 1X BRB80, 1 mM DTT, 0.5 mM GMPCPP. Incubate on ice for 5'-10', spin 90K 5' in TLA100 at 2?C, freeze in liquid nitrogen in 10 μl aliquots (or use fresh).

    2. Thaw GMPCPP bright seed mix by adding 9 vol of warm (37?C) BRB80 + 1 mM DTT (2 μM tubulin final) and incubate at 37?C for 30'-45'.

    3. Thaw CPP polar elongation mix and store on ice. Dilute as follows on ice:

    17 μl BRB80 + 1 mM DTT
    3 μl CPP Polar Elongation Mix

    (This results in elongation of ~1.5 μM CPP-tubulin)

    4. Incubate diluted CPP polar elongation mix at 37?C for 20 sec before adding 2 μl of polymerized bright CPP seeds.

    5. Incubate at 37?C for 1-2 hours. Pellet and resuspend or use directly.


    相關文章

    科學家將人工智能技術成功用于蛋白質復合物結構預測

    蛋白質作為構成人體組織器官的支架和主要物質,在人體生命活動中起著重要作用。蛋白質的相互作用能產生許多效應,如形成特異底物作用通道、生成新的結合位點、失活、作用底物專一性和動力學變化等,細胞的代謝、信號......

    發力癌癥分子病理診斷,無錫臻和全資收購TissueofOrigin?

    2021年9月9日,無錫臻和生物科技有限公司(以下簡稱“臻和科技”)與美國VyantBio公司簽署TissueofOrigin?(以下簡稱“TOO?”)全球權益和ZL轉讓協議,全資收購這款唯一獲FDA......

    這3個雜志撤回中國學者249篇文章,包含上交、中山等名校

    2021年7月20日,JournalofCellularPhysiology及JournalofCellularBiochemistry同時撤回了中國學者49篇文章。從2019年開始,Journalo......

    腫瘤治療的強心劑,中國學者開發腫瘤治療新策略

    磷酸甘油酸突變酶1(PGAM1)通過其代謝活性以及與其他蛋白質(例如α平滑肌肌動蛋白(ACTA2))的相互作用,在癌癥代謝和腫瘤進展中起關鍵作用。變構調節被認為是發現針對PGAM1的高選擇性和有效抑制......

    腫瘤治療的強心劑,中國學者開發腫瘤治療新策略

    磷酸甘油酸突變酶1(PGAM1)通過其代謝活性以及與其他蛋白質(例如α平滑肌肌動蛋白(ACTA2))的相互作用,在癌癥代謝和腫瘤進展中起關鍵作用。變構調節被認為是發現針對PGAM1的高選擇性和有效抑制......

    llumina宣布推出新型基因分型芯片|支持AllofUs研究計劃

    2018年12月6日,來自圣迭戈的消息——Illumina公司(納斯達克股票代碼:ILMN)今天宣布推出新型高密度基因分型芯片Infinium?GlobalDiversityArray。這款芯片設計源......

    SDSPAGE異常電泳現象及分析SDSPAGEHallofShame

    SDS-PAGE異常電泳現象及分析SDS-PAGEHallofShame.pdf  很不錯的東東~~推薦下~......

    Preparationofdenaturing6%

    Preparationofdenaturing6%polyacrylamidegelsformicrosatelliteanalysis(alsoforSSAP,high-resolutionIRAP......

    Preparationofdenaturing6%

    Preparationofdenaturing6%polyacrylamidegelsformicrosatelliteanalysis(alsoforSSAP,high-resolutionIRAP......

  • <td id="46i6g"><rt id="46i6g"></rt></td>
    <td id="46i6g"><kbd id="46i6g"></kbd></td>
  • <xmp id="46i6g"><option id="46i6g"></option><option id="46i6g"><option id="46i6g"></option></option>
  • <td id="46i6g"></td>
    亚洲日本va中文字幕久久道具